Showing posts with label Pipeline Assessment. Show all posts
Showing posts with label Pipeline Assessment. Show all posts

Thursday, 18 May 2017

Overview Of Disposable Hospital Supplies - Medical Devices Pipeline Assessment, 2017

Researchmoz added Most up-to-date research on "Overview Of Disposable Hospital Supplies - Medical Devices Pipeline Assessment, 2017" to its huge collection of research reports.

GlobalData's Medical Devices sector report, Disposable Hospital Supplies - Medical Devices Pipeline Assessment, 2017" provides an overview of Disposable Hospital Supplies currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Disposable Hospital Supplies pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Disposable Hospital Supplies under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Disposable Hospital Supplies and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1070545

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Disposable Hospital Supplies under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

Table Of Content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 9

2 Introduction 10
2.1 Disposable Hospital Supplies Overview 10

3 Products under Development 11
3.1 Disposable Hospital Supplies - Pipeline Products by Stage of Development 11
3.2 Disposable Hospital Supplies - Pipeline Products by Segment 12
3.3 Disposable Hospital Supplies - Pipeline Products by Territory 13
3.4 Disposable Hospital Supplies - Pipeline Products by Regulatory Path 14
3.5 Disposable Hospital Supplies - Pipeline Products by Estimated Approval Date 15

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1070545          

Sunday, 14 May 2017

Overview Of Refractive Surgery Devices - Medical Devices Pipeline Assessment, 2017

Researchmoz added Most up-to-date research on "Overview Of Refractive Surgery Devices - Medical Devices Pipeline Assessment, 2017" to its huge collection of research reports.

GlobalData's Medical Devices sector report, Refractive Surgery Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Refractive Surgery Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Refractive Surgery Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
- Extensive coverage of the Refractive Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1054414

- The report reviews the major players involved in the development of Refractive Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Refractive Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1054414

Thursday, 4 May 2017

2017: Overview Of Blood Glucose Meters - Medical Devices & Pipeline Assessment

Researchmoz added Most up-to-date research on "2017: Overview Of Blood Glucose Meters - Medical Devices & Pipeline Assessment" to its huge collection of research reports.

GlobalData's Medical Devices sector report, Blood Glucose Meters - Medical Devices Pipeline Assessment, 2017" provides an overview of Blood Glucose Meters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Glucose Meters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


- Extensive coverage of the Blood Glucose Meters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=1063646

- The report reviews the major players involved in the development of Blood Glucose Meters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Blood Glucose Meters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=1063646

Thursday, 30 March 2017

United States Bacterial Conjunctivitis Drugs Market - Pipeline Assessment, Size, Share, Growth, Trends and Forecast 2017 - 2024

ResearchMoz presents this most up-to-date research on "United States Bacterial Conjunctivitis Drugs Market - Pipeline Assessment, Size, Share, Growth, Trends and Forecast 2017 - 2024".

Bacterial conjunctivitis is a commonly encountered eye problem across the world, caused by various bacterial strains such as streptococci, staphylococci, chlamydial, and gonococci organisms. Majority of the cases of bacterial conjunctivitis are self-limited and acute and not a major cause of morbidity. This study provides market analysis for various antibacterial drug classes used for the treatment of bacterial conjunctivitis. The stakeholders of this study comprise established pharmaceutical companies involved in the commercialization of antibacterial drugs as well as new participants who wish to enter the U.S. market.
This market study provides a complete analysis of the bacterial conjunctivitis drugs market in the U.S. and helps in identifying various market governing factors. The market overview section provides exhaustive information of the incidence rate of bacterial conjunctivitis, list of API manufacturers, patent challenges, market trends such as drivers, restraints, and growth opportunities that currently control the dynamics of the overall market. The section also recommends and predicts the future conditions of the market. Market strategy tools such as event impact assessment and Porter’s Five Forces analysis have also been incorporated in this report to provide balanced analysis about the level of competition within the bacterial conjunctivitis drugs market in the U.S. Executive summary provided in the report encapsulates comprehensive insights about every segment considered in this study. Besides, it includes a market snapshot, which offers a glimpse into the current scenario of the bacterial conjunctivitis drugs market in the U.S. in terms of current and future market size along cumulative growth rate. Additionally, this study includes a regulatory framework segment wherein the overall regulatory scenario of the U.S. drugs policy has been described. Participant analysis tools such as market share analysis have also been included in the market overview section of the report to deliver a broad spectrum of the overall market scenario in the bacterial conjunctivitis drugs market in the U.S.
The bacterial conjunctivitis drugs market in the U.S. has been segmented based on various antibacterial drug classes. The market is segmented into major types of antibacterial drugs such as fluoroquinolones, aminoglycosides, macrolides, and others. The fluoroquinolones segment has been sub-segmented into ciprofloxacin, ofloxacin, levofloxacin, moxifloxacin, gatifloxacin, and besifloxacin. Aminoglycosides has been sub-segmented into tobramycin and gentamycin. Macrolides has been divided into erythromycin and azithromycin. The others segment is analyzed cumulatively, considering bacitracin, fusidic acid and ceftriaxone within this class. The market size for the period from 2012 to 2024 has been provided for each of the major drug classes mentioned above in terms of USD million. Along with the market size that were projected considering 2013 as the base year and 2012 as the historical year, the CAGR (%) of each market segment for the forecast period from 2012 to 2018 and 2018 to 2024 have also been provided.


The report concludes with detailed profiles of leading players in the bacterial conjunctivitis drugs (antibacterials) market in the U.S. The study profiles the companies in terms of overview, financial overview, product portfolio, business strategies, and recent developments. Major organizations profiled in this report include Actavis plc, Akorn, Inc., Bayer AG, F. Hoffmann-La Roche, Ltd., Merck & Co., Inc., Novartis AG, Perrigo Company plc, Pfizer, Inc., Santen Pharmaceutical Co., Ltd., and Valeant Pharmaceuticals International, Inc. Additionally, market share analysis that has been provided in context with the major pharmaceuticals operating in the market would help new participants to understand the key business perceptions and frameworks and to identify the specific product lines of the existing companies to establish a strong foothold in the bacterial conjunctivitis drugs market in the U.S.
The U.S. bacterial conjunctivitis drugs market is segmented as follows:
U.S. Bacterial Conjunctivitis Drugs Market, by Drug Class
  • Fluoroquinolones
  • Ciprofloxacin
  • Ofloxacin
  • Levofloxacin
  • Moxifloxacin
  • Gatifloxacin
  • Besifloxacin
  • Aminoglycosides
  • Tobramycin
  • Gentamycin
  • Macrolides
  • Erythromycin
  • Azithromycin
  • Others
U.S. Bacterial Conjunctivitis Drugs Market, Pipeline Assessment
  • Vancomycin Ophthalmic Ointment
  • Early Stage (Phase I and Phase II trials) – Tabular Representation

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=759857

Tuesday, 17 January 2017

Medical Devices For Pancreatic Cancer Diagnostic Tests - Pipeline Assessment, 2020

Researchmoz added Most up-to-date research on "Medical Devices For Pancreatic Cancer Diagnostic Tests - Pipeline Assessment, 2020" to its huge collection of research reports.

GlobalData's Medical Devices sector report, Pancreatic Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Pancreatic Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Pancreatic Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Pancreatic Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=885312

- The report reviews the major players involved in the development of Pancreatic Cancer Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Pancreatic Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=885312

Comprehensive Information On Dental Biomaterials - Medical Devices Pipeline Assessment, 2018

ResearchMoz presents this most up-to-date research on "Comprehensive Information On Dental Biomaterials - Medical Devices Pipeline Assessment, 2018".

GlobalData's Medical Devices sector report, Dental Biomaterials - Medical Devices Pipeline Assessment, 2016" provides an overview of Dental Biomaterials currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dental Biomaterials pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Dental Biomaterials under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Dental Biomaterials and list all their pipeline projects

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=885314

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Dental Biomaterials under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=885314

Overview Of Ultrasound Systems In Pipeline Stage: Medical Device, 2018

Researchmoz added Most up-to-date research on "Overview Of Ultrasound Systems In Pipeline Stage: Medical Device, 2018" to its huge collection of research reports.

GlobalData's Medical Devices sector report, Ultrasound Systems - Medical Devices Pipeline Assessment, 2016" provides an overview of Ultrasound Systems currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Ultrasound Systems pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope


- Extensive coverage of the Ultrasound Systems under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Ultrasound Systems and list all their pipeline projects

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=885315

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Ultrasound Systems under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=885315

Diagnostic Tests For Breast Cancer: Medical Devices Pipeline Assessment, 2017

Researchmoz added Most up-to-date research on "Diagnostic Tests For Breast Cancer: Medical Devices Pipeline Assessment, 2017" to its huge collection of research reports.

GlobalData's Medical Devices sector report, Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overview of Breast Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Breast Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Breast Cancer Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Breast Cancer Diagnostic Tests and list all their pipeline projects

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=885316

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to - 
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Breast Cancer Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=885316